You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
牛津大学与阿斯利康据报正检视是否需要调整新冠疫苗应对变种
阿思达克 01-21 11:50
英国《每日电讯报》报道,牛津大学科学家正预备快速生产与阿斯利康药厂(AZN.US)共同研发新冠疫苗的新版本,应对英国、南非及巴西出现的变种。报道引述牛津大学指,双方研究团队正研究调整疫苗技术的可行性,并估算调整疫苗平台所需时间。

牛津大学发言人向《路透》表示,他们正小心检视变种对疫苗防疫能力的影响,并检讨是否需要快速推出经调整疫苗。

最新研究指辉瑞(PFE.US)及BioNTech(BNTX.US)共同研发的新冠疫苗,有效应对英国变种。BioNTech早前表示,计划数日内公布疫苗应对南非变种病毒的研究结果。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account